Form 4: Kronos Bio, Inc. Executive Acquires Stock Options
SEC Form 4
Allison Frisbee, Chief Administrative Officer of Kronos Bio, Inc., reports the acquisition of stock options.
Summary
- On October 15, 2024, Allison Frisbee, Chief Administrative Officer of Kronos Bio, Inc., acquired employee stock options.
- The options grant the right to buy 72,900 shares of Kronos Bio's common stock at an exercise price of $0.96 per share.
- The options vest in equal monthly installments over a four-year period, starting October 15, 2024.
- Following the transaction, Ms. Frisbee directly owns 72,900 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option acquisition.
Positives
- The acquisition of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard Form 4 filing, which is common for corporate insiders who have transactions in their company's stock. It provides transparency into the trading activities of key personnel.
Key Dates
| Date | Description |
|---|---|
| 10/15/2024 | Date of the stock option transaction. |
| 10/15/2024 | Vesting start date for the stock options. |
| 10/14/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.